Downloading...
Download
VanEck Biotech ETFVanEck Biotech ETFVanEck Biotech ETF

VanEck Biotech ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

VanEck Biotech ETF holdings


As of July 28, 2025
Symbol
Weight %
Shares
Market value
A
AMGNAmgen Inc.
15.99%
‪‪182.50 K‬‬
‪‪54.98 M‬‬USD
G
GILDGilead Sciences, Inc.
12.78%
‪‪388.86 K‬‬
‪‪43.95 M‬‬USD
V
VRTXVertex Pharmaceuticals Incorporated
10.30%
‪‪76.84 K‬‬
‪‪35.41 M‬‬USD
I
IQVIQVIA Holdings Inc
5.32%
‪‪92.45 K‬‬
‪‪18.28 M‬‬USD
R
REGNRegeneron Pharmaceuticals, Inc.
5.11%
‪‪31.46 K‬‬
‪‪17.58 M‬‬USD
A
ARGXargenx SE Sponsored ADR
4.91%
‪‪28.37 K‬‬
‪‪16.89 M‬‬USD
A
ALNYAlnylam Pharmaceuticals, Inc
4.64%
‪‪49.17 K‬‬
‪‪15.97 M‬‬USD
I
ICLRICON Plc
3.92%
‪‪71.16 K‬‬
‪‪13.50 M‬‬USD
N
NTRANatera, Inc.
3.53%
‪‪88.05 K‬‬
‪‪12.15 M‬‬USD
I
INSMInsmed Incorporated
3.46%
‪‪117.01 K‬‬
‪‪11.91 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.